You are here: Industry Insights > revenue

News List

PureTech Health reports increase in 2020 revenue pharmaceutical-technology
April 16, 2021
PureTech Health has reported an increase in revenue to $11.77m last year from $9.81m in 2019.
111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results prnasia
March 19, 2021
111, Inc. announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.
EDAN Announces 2020 Annual Results and 2025 Outlook: Revenues Increased 104.1% prnasia
March 17, 2021
EDAN Instruments, Inc. on Monday announced its results for the preceding fiscal year (FY 2020) with revenue of CNY 2.3 billion. The company also revealed its strategic 5+1 plan and its anticipation for 2025.
Financial Report. Roche contractpharma
February 07, 2021
Newly launched medicines Tecentriq, Hemlibra, Ocrevus, Perjeta and Kadcyla offset the impact of competition from biosimilars for established medicines.
Regeneron 4Q and FY20 Results contractpharma
February 07, 2021
REGEN-COV antibody cocktail for COVID-19 received FDA EUA; Net sales of REGEN-COV were $146 million in the quarter and $186 million for the year.
Financial Report. Lilly contractpharma
February 07, 2021
Recognizes worldwide revenue of $871.2 million in the quarter for bamlanivimab COVID-19 treatment.
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results prnasia
November 18, 2020
China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.
GSK Pharma announces results for the quarter ended June 30, 2020 expresspharma
July 30, 2020
GlaxoSmithKline Pharmaceuticals declared its financial results for the quarter ended June 30, 2020. Revenue for the quarter came in at Rs 649 crores as against Rs 787.97 crores for the same period last year.
Biocon releases Q1FY21 results; Revenue up by 14 per cent at Rs 1,690 Cr expresspharma
July 27, 2020
The company's Research Services business reported flat revenue growth at Rs 422 Crore due to slowdown of operations impacted by the COVID-19 crisis.
Syngene announces Q1 FY21 results; Revenue stands at Rs. 437 Cr expresspharma
July 24, 2020
The company posted quarterly revenue of Rs. 437 Cr, in line with guidance: Profit After Tax, was impacted less than expected, at Rs. 58 Cr for the quarter.

Previous page 1 2 3 4 5 Next page